CompletedNCT03785223
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Medication studyAges 18–65Canada
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Hamilton, CanadaSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: April 20, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- McMaster University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03785223
- Official title
Show the full official title
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Recruitment & locations
CompletedHamilton
Questions about this study
Who is behind this study?
The study sponsor is McMaster University, a university.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate Hydrochloride Controlled-Release Capsules and Placebo Capsule.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01886469
A Phase II, Adaptive study Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
Canada
CompletedNCT05604794
A Retrospective Effectiveness study of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health
United States, Canada
CompletedNCT02432703
Safety study of JNJ-42165279 in anxiety
Researchers compared JNJ-42165279 and placebo, tracking side effects to assess safety and tolerability in people with an anxiety condition.